ArticleOncotarget2017
Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism.
Yong Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it
ArticleOncotarget2017
Yong Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.